World's Best Scientists 2026 revealed!
David H. Harpole

David H. Harpole

D-Index & Metrics

Medicine

D-Index
79
Citations
24078
World Ranking
17512
National Ranking
8764

David H. Harpole publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where David H. Harpole sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 296 publications — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

David H. Harpole D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where David H. Harpole sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 79 D-Index — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

David H. Harpole is affiliated with Duke University in the United States. Their research primarily focuses on medicine, with a significant emphasis on pulmonary and respiratory medicine, surgery, oncology, radiology, nuclear medicine and imaging, as well as cardiology and cardiovascular medicine.

Their work covers several main topics including lung cancer diagnosis and treatment, lung cancer treatments and mutations, esophageal cancer research and treatment, gastric cancer management and outcomes, esophageal and gastrointestinal pathology, cancer immunotherapy and biomarkers, and lung cancer research studies.

Notable recent publications by David H. Harpole include:

  • Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer, 2023, New England Journal of Medicine
  • Perioperative outcomes of pulmonary resection after neoadjuvant pembrolizumab in patients with non-small cell lung cancer, 2021, Journal of Thoracic and Cardiovascular Surgery
  • Design and Rationale for a Phase III, Double-Blind, Placebo-Controlled Study of Neoadjuvant Durvalumab + Chemotherapy Followed by Adjuvant Durvalumab for the Treatment of Patients With Resectable Stages II and III non-small-cell Lung Cancer: The AEGEAN Trial, 2021, Clinical Lung Cancer
  • Abstract CT005: AEGEAN: A phase 3 trial of neoadjuvant durvalumab + chemotherapy followed by adjuvant durvalumab in patients with resectable NSCLC, 2023, Cancer Research
  • Stellate Ganglion Blockade for the Treatment of Refractory Ventricular Arrhythmias, 2020, JACC. Clinical electrophysiology

David H. Harpole frequently collaborates with several researchers, including Betty C. Tong, Thomas A. D'Amico, Vignesh Raman, Oliver K. Jawitz, and John V. Heymach.

Their findings are often published in prominent venues such as the Journal of Thoracic Oncology, Journal of Thoracic and Cardiovascular Surgery, The Annals of Thoracic Surgery, Annals of Surgery, and Journal of Clinical Oncology.

Best Publications

  • Oncogenic pathway signatures in human cancers as a guide to targeted therapies.

    Andrea H. Bild;Guang Yao;Jeffrey T. Chang;Quanli Wang

  • Adjuvant Paclitaxel Plus Carboplatin Compared With Observation in Stage IB Non–Small-Cell Lung Cancer: CALGB 9633 With the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups

    Gary M. Strauss;James E. Herndon;Michael A. Maddaus;David W. Johnstone

  • Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: A propensity-matched analysis from the STS database

    Subroto Paul;Nasser K. Altorki;Shubin Sheng;Paul C. Lee

  • Morbidity and Mortality of Major Pulmonary Resections in Patients With Early-Stage Lung Cancer: Initial Results of the Randomized, Prospective ACOSOG Z0030 Trial

    Mark S. Allen;Gail E. Darling;Taine T.V. Pechet;John D. Mitchell

  • Retraction: Genomic signatures to guide the use of chemotherapeutics

    Anil Potti;Holly K Dressman;Andrea Bild;Richard F Riedel

  • A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer.

    Anil Potti;Sayan Mukherjee;Rebecca Petersen;Holly K. Dressman

  • Data from The Society of Thoracic Surgeons General Thoracic Surgery database: The surgical management of primary lung tumors

    Daniel J. Boffa;Mark S. Allen;Joshua D. Grab;Henning A. Gaissert

  • Tumor infiltrating Foxp3+ regulatory T‐cells are associated with recurrence in pathologic stage I NSCLC patients

    Rebecca P. Petersen;Michael J. Campa;Justin Sperlazza;Debbi Conlon

  • Outcomes after esophagectomy: a ten-year prospective cohort

    Stephen H Bailey;David A Bull;David H Harpole;Jeffrey J Rentz

  • Reducing hospital morbidity and mortality following esophagectomy

    B.Zane Atkins;Ashish S. Shah;Kelley A. Hutcheson;Jennifer H. Mangum

  • A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo

    Laura R. Saunders;Alexander J. Bankovich;Wade C. Anderson;Monette A. Aujay

  • Thoracoscopic Lobectomy Is a Safe and Versatile Procedure: Experience With 500 Consecutive Patients

    Mark W. Onaitis;Rebecca P. Petersen;Stafford S. Balderson;Eric Toloza

  • Thoracoscopic lobectomy is associated with lower morbidity compared with thoracotomy.

    Nestor R. Villamizar;Marcus D. Darrabie;William R. Burfeind;Rebecca P. Petersen

  • Hypermethylated APC DNA in Plasma and Prognosis of Patients With Esophageal Adenocarcinoma

    Kazuyuki Kawakami;Jan Brabender;Reginald V. Lord;Susan Groshen

  • A Prognostic Model of Recurrence and Death in Stage I Non-Small Cell Lung Cancer Utilizing Presentation, Histopathology, and Oncoprotein Expression

    Harpole Dh;Herndon Je nd;Wolfe Wg;Iglehart Jd

  • Prognostic models of thirty-day mortality and morbidity after major pulmonary resection.

    David H. Harpole;Malcolm M. DeCamp;Jennifer Daley;Kwan Hur

  • Thoracoscopic Lobectomy Facilitates the Delivery of Chemotherapy after Resection for Lung Cancer

    Rebecca P. Petersen;Duy Khanh Pham;William R. Burfeind;Steven I. Hanish

  • Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non–small cell lung cancer

    Carolyn E Reed;David H Harpole;Katherine E Posther;Sandra L Woolson

  • Predictive value of the EphA2 receptor tyrosine kinase in lung cancer recurrence and survival.

    Michael S. Kinch;Mary-Beth Moore;David H. Harpole

  • A biologic risk model for stage I lung cancer: Immunohistochemical analysis of 408 patients with the use of ten molecular markers

    Thomas A. D'Amico;Marga Massey;James E. Herndon Ii;Mary-Beth Moore

Frequent Co-Authors

Thomas A. D'Amico
Thomas A. D'Amico Duke University
James E. Herndon
James E. Herndon Duke University
David J. Sugarbaker
David J. Sugarbaker Baylor College of Medicine
Raphael Bueno
Raphael Bueno Brigham and Women's Hospital
Joseph R. Nevins
Joseph R. Nevins Duke University
William G. Richards
William G. Richards Brigham and Women's Hospital
Karla V. Ballman
Karla V. Ballman Cornell University
Jeffrey R. Marks
Jeffrey R. Marks Duke University
Andrew Berchuck
Andrew Berchuck Duke University
Valerie W. Rusch
Valerie W. Rusch Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in the broader field of healthcare or seeking alternative routes into medical careers? There are several flexible online programs that can kickstart or advance your journey. For those passionate about nutrition and patient wellness, an online BS in nutrition provides foundational science knowledge and prepares you for roles in public health, counseling, or food science.

If your goal is to move into healthcare leadership, consider pursuing one of the CAHME-accredited Master of Healthcare Administration (MHA) programs online. These programs are recognized for quality and can open doors to management positions in hospitals, clinics, and health systems.

Registered Nurses aiming to advance their careers may opt for RN BSN online programs no clinicals, which allow you to earn your BSN with minimal on-site requirements—ideal for working professionals.

Lastly, those wishing to reach the highest clinical level can explore accelerated MSN to DNP programs. These rigorous online paths help nurses gain advanced practice skills in less time.

Best Scientists Citing David H. Harpole

Trending Scientists